PublishedDecember 5, 2013

Innovation Act Passes House 325-91, Patent Trolls Cry

dewey defeats truman - patent trolls win

It was a big day in the land of patent troll reform, as the House resoundingly passed the Innovation Act with strong support from both sides of the aisle. The bill has some great features, including:

  • greater disclosure by patent owners so that accused infringers know what they’re accused of

  • discovery reforms to streamline and reduce the cost of patent litigation

  • a customer stay provision so that if someone is accused of patent infringement based on a product purchased “off the shelf”, the manufacturer can (with the consent of the accused infringer) step in to conduct the defense

If there was a real disappointment, it was that the “concern trolls” won this round by managing to keep any improvement of the covered business method review program out of the bill. Using everything from misleading statements to out-and-out falsehoods, a handful of protectors of the status quo created a panic about what should have been a fairly non-controversial provision.

I’ll be writing more about that in the days to come, because as we move to the Senate next, we don’t seem to have lost momentum: the Senate Judiciary Committee is having a hearing on December 17 on the patent troll issue.

And for all you patent trolls out there, here’s a little music for you (I apologize if there’s a commercial at the beginning, but it’s the official video):

[youtube_embed id=’Z0GFRcFm-aY’]

Matt Levy

Previously, Matt was patent counsel at the Computer & Communications Industry Association

More Posts

The Ripple Effects of Patent Venue

A recent article described the outsized roles that two modest cities in Texas play in U.S. patent litigation, but there's more to the story of America’s odd patent venue rules. The article alludes t...

Another startup bites the dust, courtesy of patent trolls

A handful of interest groups like to claim that patent trolls are a myth—that they're a straw man used to shape IP policy in ways that are harmful to patent holders. Mycroft AI is one of many startu...

How Challenging Low Quality Patents is Lowering Drug Prices

The FTC made headlines in May when it announced it was challenging over 300 “junk” patents in the FDA’s “Orange Book,” including patents on popular drugs like Ozempic and Victoza. With this ...

Subscribe to Patent Progress

No spam. Unsubscribe anytime.